| Literature DB >> 19128462 |
Magnus Edner1, Yong Kim, Knud Norregaard Hansen, Henrik Nissen, Geert Espersen, Karl La Rosee, Fikru Maru, Nick Freemantle, John Cleland, Peter Sogaard.
Abstract
BACKGROUND: Cardiac resynchronisation therapy (CRT) improves mortality and morbidity in heart failure patients with wide QRS. Observational studies suggest that patients having more left ventricular dyssynchrony pre-implantation obtain greater benefit on ventricular function and symptoms with CRT. AIM: To provide an analysis of the prevalence and type of dyssynchrony in patients included in the CARE-HF trial.Entities:
Mesh:
Year: 2009 PMID: 19128462 PMCID: PMC2630933 DOI: 10.1186/1476-7120-7-1
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Figure 1TVI-, DLC-curves and TSI illustrating dyssynchrony. TVI curves (left) showing late systolic peak velocity in the posterior segments (yellow and blue). TSI (right), is a signal-processing algorithm of the tissue Doppler data to automatically detect peak positive velocity and then colour-code the time to peak velocities in green for normal timing, yellow-orange for moderate delay, and red for severe delay, in peak velocity showing dyssynchrony (orange) in the corresponding posterior segments and SR curves showing delayed longitudinal contraction (DLC, yellow) in the same segment after aortic valve closure (AVC).
Baseline Characteristics
| Age [years] | 67.1 (57.6, 71.3) | 66.4 (59.5, 72.0) | 0.71 |
| Male gender | 66 (66.0) | 531 (74.5) | 0.09 |
| Ischemic History | 47 (47.0) | 292 (41.0) | 0.28 |
| Diabetes | 24 (24.0) | 183 (25.7) | 0.81 |
| Duration of HF, [months] | 4.3 (1.5, 8.1) | 4.0 (1.5, 7.9) | 0.80 |
| ACE/ARB | 97 (97.0) | 673 (94.4) | 0.35 |
| Betablockers | 83 (83.0) | 503 (70.6) | 0.009 |
| Loop Diuretics ≥ 80 mg furosemide or equivalent | 63 (63.0) | 289 (40.5) | <.0001 |
| Aldosterone antagonists | 73 (73.0) | 384 (53.9) | 0.0003 |
| Digoxin | 53 (53.0) | 293 (41.1) | 0.03 |
| Aspirin | 68 (68.0) | 292 (41.0) | <.0001 |
| Warfarin | 28 (28.0) | 249 (34.9) | 0.18 |
| Statins | 37 (37.0) | 284 (39.8) | 0.66 |
HF = heart failure, ACE = angiotensin converting enzyme inhibitors, ARB = angiotensin receptor blockers. Median, (IQR).
ECG, NT-proBNP and echocardiography.
| Heart rate [bpm] | 69 (60, 78) | 69 (61, 78) | 0.93 |
| QRS [ms] | 160 (150, 172) | 160 (152, 180) | 0.20 |
| Systolic blood pressure, (mm Hg) | 120 (108, 130) | 117 (105, 130) | 0.76 |
| Diastolic blood pressure, (mm Hg) | 70 (64, 80) | 70 (60, 80) | 0.21 |
| N-terminal-pro-brain natriuretic peptide (pg/ml) | 2275 (905, 5277) | 1768 (736, 4009) | 0.06 |
| Enddiastolic diameter (mm) | 7.5 (6.5, 8.0) | 7.1 (6.4, 7.8) | 0.87 |
| Endsystolic diameter [mm] | 6.1 (5.4, 6.9) | 6.4 (5.5, 7.1) | 0.79 |
| Ejection fraktion, [%] | 24.6 (20.4, 30.2) | 24.7 (21.7, 28.9) | 0.94 |
Median (IQR), ECG = electrocardiogram.
Signs of dyssynchrony in the sub study patients, n = 100
| LVFT, ms, | 400.0 (312.6, 494.9) | 372.8 (280.8, 477.1) | 426.9 (346.5, 519.1) | 0.03 |
| LVFT as % of RR | 44.6 (38.6, 52.1) | 42.5 (36.4, 50.2) | 47.0 (41.5, 54.1) | 0.02 |
| No of pts <40% (%) | 34 (34.0) | 24 (45.3) | 10 (21.3) | 0.02 |
| IVMD, ms | 47.9 (27.4, 62.0) | 50.5 (33.3, 69.7) | 41.1(23.9, 58.3) | 0.11 |
| No of pts with IVMD >40 ms (%) | 60 (60.0) | 37 (69.8) | 23 (48.9) | 0.09 |
| Base-segments [ | ||||
| No of pts with DLC(%) | 85 (85.0) | 47 (88.7) | 38 (80.9) | 0.40 |
| No of segments with DLC | 2 (1, 3) | 3 (2, 3) | 2 (1, 2) | 0.05 |
| Mid-segments [ | ||||
| No of pts with DLC(%) | 70 (70.0) | 42 (79.2) | 28 (59.6) | 0.05 |
| No of segments with DLC | 2 (0, 2) | 2 (1, 2) | 1 (0, 2) | 0.02 |
| Apical-segments, [ | ||||
| No of pts with DLC | 0 | 0 | 0 | |
| 16-segments model | ||||
| No of pts with DLC | 85 (85.0) | 47 (88.7) | 38 (80.9) | 0.40 |
| No of segments with DLC | 4 (2, 5) | 4 (3, 5) | 3 (1, 4) | 0.003 |
| Base-segments [ | ||||
| No of pts with TSI(%) | 86 (86.0) | 48 (90.6) | 38 (80.9) | 0.25 |
| No of segments with TSI | 2 (1, 3) | 3 (2, 3) | 2 (1, 2) | 0.03 |
| Mid-segments [ | ||||
| No of pts with TSI(%) | 69 (69.0) | 42 (79.2) | '27 (57.4) | 0.03 |
| No of segments with TSI | 2 (0, 2) | 2 (1, 2) | 1 (0, 2) | 0.03 |
| Apical segments, 4 | ||||
| No of pts with TSI | 0 | 0 | 0 | |
| 16-segments model | ||||
| No of pts with TSI(%) | 86 (86.0) | 48 (90.6) | 38 (80.9) | 0.25 |
| No of segments with TSI | 4 (2, 5) | 4 (3, 5) | 3 (1, 4) | 0.002 |
Median (IQR), n (%). LVFT = left ventricular filling time, IVMD = Inter ventricular mechanical delay, DLC = delayed longitudinal contraction, TSI = tissue synchronisation imaging, IDCM = idiopathic dilated cardiomyopathy, IHD = ischemic heart disease.
Figure 2Distribution of intra-ventricular dyssynchrony in affected segments in the heart failure population, n = 100.
TSI and DLC count univariate analysis
| Variable | Relative Risk (95 CI) | P value | Relative Risk (95% CI) | P value |
| Age | 0.998 (0.988 to 1.007) | 0.625 | 0.997 (0.987 to 1.007) | 0.52 |
| Male gender | 0.698 (0.563 to 0.866) | 0.001 | 0.692 (0.559 to 0.858) | 0.0007 |
| IHD | 0.710 (0.563 to 0.866) | 0.002 | 0.718 (0.576 to 0.890) | 0.003 |
| Heart rate | 1.008 (0.999 to 1.016) | 0.068 | 1.008 (0.999 to 1.016) | 0.08 |
| Systolic BP, mmHg | 1.003 (0.997 to 1.009) | 0.313 | 1.003 (0.997 to 1.009) | 0.26 |
| NT-proBNP, pg/ml | 0.984 (0.909 to 1.065) | 0.685 | 0.982 (0.908 to 1.062) | 0.65 |
| QRS, ms | 1.006 (1.001 to 1.012) | 0.032 | 1.006 (1.000 to 1.012) | 0.03 |
| LVESVi, ml/m2 | 1.002 (1.000 to 1.004) | 0.0694 | 1.002 (1.000 to 1.004) | 0.08 |
| LVEDVi, ml/m2 | 1.002 (1.000 to 1.004) | 0.0984 | 1.002 (1.000 to 1.004) | 0.12 |
| EF, % | 0.987 (0.970 to 1.003) | 0.11 | 0.986 (0.970 to 1.002) | 0.10 |
IHD = ischemic heart disease, BP = blood pressure, NT-proBNP = N-terminal brain natriuretic peptide, LVESVi = left ventricular end systolic volume/m2, EF = ejection fraction.
Combinations of different types of dyssynchrony, n = 100
| LVFT/RR + IVMD, (%) | 25 (25.0) | 19 (35.8) | 6 (12.7) | 0.02 |
| LVFT/RR + Intra-v (DLC), (%) | 32 (32.0) | 23 (43.4) | 9 (19.1) | 0.02 |
| LVFT/RR + Intra-v (TSI), (%) | 33 (33.0) | 24 (45.3) | 9 (19.1) | 0.01 |
| LVFT//RR + Intra-v (DLC or TSI), (%) | 33 (33.0) | 24 (45.3) | 9 (19.1) | 0.02 |
| IVMD + Intra-v, (DLC or TSI) (%) | 51 (51.0) | 33 (62.3) | 18 (38.3) | 0.04 |
| LVFT/RR + IVMD + Intra-v (DLC or TSI), (%) | 23 (23.0) | 18 (34.0) | 5 (10.6) | 0.01 |
Abbreviations see table 3.
Figure 3Distribution of intra-ventricular dyssynchrony in affected segments in patients with cardiomyopathy n = 53 (left) and ischemic heart disease n = 47 (right).
Figure 4Tissue synchronization imaging (TSI) showing delayed lateral systolic contraction in red colour with corresponding TVI-curves. AVO and AVC = aortic valve opening and closure.
Figure 5Tissue synchronization imaging (TSI) showing inferior delayed systolic contraction in red colour with corresponding TVI-curves. The TSI-technique is timesaving and makes it easy to find intra ventricular regions with dyssynchrony. Abbreviations see fig 4.